Ra Capital Management, L.P. - Director, 10%+ Owner at Aerovate Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
Director, 10%+ Owner
Stock Symbol
AVTE on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Ra Capital Management, L.P. since 10/5/2023

Holdings reported by Ra Capital Management, L.P. for Aerovate Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 7.89M $198M $25.03 Jun 17, 2024 Indirect
Stock Option (Right to Buy) 12.5K $205K $16.37 Jun 5, 2024 Indirect Common Stock

Transactions reported by Ra Capital Management, L.P. for Aerovate Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.